Sipuleucel-T Combined With Bipolar Androgen Therapy in Men With mCRPC

Conditions: Metastatic Castration-resistant Prostate Cancer Interventions: Drug: Testosterone Cypionate; Drug: Sipuleucel-T Sponsors: Yale University; Dendreon Not yet recruiting

https://clinicaltrials.gov/study/NCT06100705

Source: ClinicalTrials.gov - October 25, 2023 Category: Research Source Type: clinical trials